Published in Arterioscler Thromb Vasc Biol on May 07, 2010
Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res (2011) 2.31
Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med (2011) 1.94
Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res (2013) 1.43
Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng (2011) 1.26
Angiogenesis in the infarcted myocardium. Antioxid Redox Signal (2012) 1.15
Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res (2015) 0.94
Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes. Diabetes (2012) 0.94
Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS One (2011) 0.92
Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo. PLoS One (2012) 0.91
Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology. Circ Res (2016) 0.91
Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization. PLoS One (2013) 0.89
Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis. Stem Cells (2013) 0.88
Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice. PLoS One (2012) 0.85
CD34⁺/M-cadherin⁺ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE⁻/⁻ mice. PLoS One (2011) 0.84
Omental grafting: a cell-based therapy for blood vessel repair. J Tissue Eng Regen Med (2012) 0.83
Angiogenic Mechanisms of Human CD34(+) Stem Cell Exosomes in the Repair of Ischemic Hindlimb. Circ Res (2017) 0.82
The secretome of endothelial progenitor cells promotes brain endothelial cell activity through PI3-kinase and MAP-kinase. PLoS One (2014) 0.82
Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration. Sci Rep (2015) 0.80
The Pathophysiology of Moyamoya Disease: An Update. J Stroke (2016) 0.78
Echocardiographic evaluation of the effects of stem cell therapy on perfusion and function in ischemic cardiomyopathy. J Am Soc Echocardiogr (2013) 0.78
Repertoire of endothelial progenitor cells mobilized by femoral artery ligation: a nonhuman primate study. J Cell Mol Med (2012) 0.78
Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation. Stem Cells Transl Med (2016) 0.76
A subset of cerebrovascular pericytes originates from mature macrophages in the very early phase of vascular development in CNS. Sci Rep (2017) 0.75
Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia. Circ Res (2017) 0.75
The injury theory, endothelial progenitors, and sleep apnea. Am J Respir Crit Care Med (2013) 0.75
Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb. J Cell Mol Med (2017) 0.75
Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood (2005) 2.72
Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation (2003) 2.42
Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol (2004) 2.39
MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int (2005) 2.25
Smooth muscle progenitor cells in human blood. Circulation (2002) 2.15
Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation (2006) 1.66
Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction. Circ Cardiovasc Interv (2011) 1.62
Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med (2006) 1.61
Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med (2007) 1.45
Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke (2004) 1.34
Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol (2005) 1.22
Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation (2003) 1.08
Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis (2005) 1.05
Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev (2008) 1.01
Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol (2005) 1.01
Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med (2004) 0.98
Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1. Eur Heart J (2011) 0.95
Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation (2004) 0.94
Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J (2009) 0.94
Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling. Thromb Haemost (2003) 0.93
Deficiency of CX3CR1 delays burn wound healing and is associated with reduced myeloid cell recruitment and decreased sub-dermal angiogenesis. Burns (2011) 0.92
Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization. PLoS One (2013) 0.89
Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam". J Am Coll Cardiol (2011) 0.89
Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis (2007) 0.88
Cyclosporine decreases vascular progenitor cell numbers after cardiac transplantation and attenuates progenitor cell growth in vitro. J Heart Lung Transplant (2005) 0.86
A specific subset of mouse bone marrow cells has smooth muscle cell differentiation capacity-brief report. Arterioscler Thromb Vasc Biol (2009) 0.84
Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. Clin Cardiol (2004) 0.83
Vascular disease: a new progenitor biology. Curr Vasc Pharmacol (2007) 0.82
Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells. Biochim Biophys Acta (2013) 0.82
A tissue-engineered stent for cell-based vascular gene transfer. Hum Gene Ther (2002) 0.82
New therapeutic potential of microRNA treatment to target vulnerable atherosclerotic lesions and plaque rupture. Curr Opin Cardiol (2011) 0.81
Myeloid lineage of human endothelial outgrowth cells circulating in blood and vasculogenic endothelial-like cells in the diseased vessel wall. J Vasc Res (2009) 0.81
Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation (2009) 0.80
Endothelial progenitor cells. Endothelium (2006) 0.79
Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction. Mol Pharm (2015) 0.79
Clinical trials in stem cell therapy: pitfalls and lessons for the future. Nat Clin Pract Cardiovasc Med (2007) 0.78
Targeting angiogenesis versus myogenesis with cardiac cell therapy. Expert Rev Cardiovasc Ther (2006) 0.77
Functional food addressing heart health: do we have to target the gut microbiota? Curr Opin Clin Nutr Metab Care (2015) 0.77
Calcium signalling in adult endothelial outgrowth cells. Biochem Biophys Res Commun (2011) 0.77
Stem cells to repair the heart: a clinical perspective. Circ Res (2003) 0.77
Contrast-enhanced ultrasound and the enigma of plaque neovascularization. JACC Cardiovasc Imaging (2010) 0.77
Selective M2 Macrophage Depletion Leads to Prolonged Inflammation in Surgical Wounds. Eur Surg Res (2017) 0.77
PAF-receptor is preferentially expressed in a distinct synthetic phenotype of smooth muscle cells cloned from human internal thoracic artery: functional implications in cell migration. Biochem Biophys Res Commun (2006) 0.76
Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clin Proc (2004) 0.76
Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens. Arterioscler Thromb Vasc Biol (2011) 0.75
Improved protocol for processing stented porcine coronary arteries for immunostaining. J Mol Histol (2011) 0.75
Differential endothelial coverage, response to injury and neointimal integration of CX3CR1/smooth muscle-like cells after carotid or femoral arterial injury. J Vasc Res (2013) 0.75
Nitric oxide synthase gene transfer as a tool to study biology of endothelial cells. Arterioscler Thromb Vasc Biol (2003) 0.75
Pleiotropic role for monocyte C-fms protein in response to vascular injury: potential therapeutic target. Atherosclerosis (2011) 0.75
Progression of nonculprit plaque stenosis following successful percutaneous intervention. Angiology (2008) 0.75
Multidetector computed tomography accurately defines infarct size, but not microvascular obstruction after myocardial infarction. J Am Coll Cardiol (2012) 0.75